Dehydrozingerone, a Curcumin Analog, as a Potential Anti-Prostate Cancer Inhibitor in Vitro and in Vivo

Dehydrozingerone, a Curcumin Analog, as a Potential Anti-Prostate Cancer Inhibitor in Vitro and in Vivo

© 2020 MDPI AG. All rights reserved. Curcumin (Cur) exhibits biological activities that support its candidacy for cancer treatment. However, there are limitations to its pharmacological effects, such as poor solubility and bioavailability. Notably, the use of Cur analogs has potential for addressing...

Full description

Saved in:
Bibliographic Details
Main Authors: Sariya Mapoung, Shugo Suzuki, Satoshi Fuji, Aya Naiki-Ito, Hiroyuki Kato, Supachai Yodkeeree, Natee Sakorn, Chitchamai Ovatlarnporn, Satoru Takahashi, Pornngarm Limtrakul
Format: Journal
Published: 2020
Subjects:
Biochemistry, Genetics and Molecular Biology
Chemistry
Pharmacology, Toxicology and Pharmaceutics
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85086687135&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/70226
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University

Internet

https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85086687135&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/70226

Similar Items